Medical Companies in Spain

IOMED has developed a Natural Language Processing tool that allows hospitals to structure their information identifying clinically relevant variables from medical notes and structuring them into datasets, which can then be easily queried. Thanks to this data structuration, professionals and researchers from the hospitals can access to the information stored in their facilities more quickly thus accelerating patient recruitment by reducing the time invested in this process. At the same time, it allows hospitals to improve the quality of their services. Overall, we accelerate Clinical Research through the use of Artificial Intelligence, allowing access to structured RWD from hospital medical records and considerably optimizing your studies in time and access to patient volume. Finally, data protection is IOMED’s priority and we work to ensure a safe and secure environment: each hospital decides and authorizes all data uses and participation in projects, the data is stored entirely within the hospital, and always following international and Spanish legislation.

AMADIX is a leading molecular diagnostics company focused on liquid biopsy, developing innovative diagnostic tests for early cancer detection in blood. The mission of the company is extending people's lives, developing disruptive technologies to detect the tumor years in advance, before the symptoms appear.

Health is the level of functional or metabolic efficiency of a living organism. In humans it is the ability of individuals or communities to adapt and self-manage when facing physical, mental or social challenges.

At Koa Health, we’ve made it our mission to leverage technology and research to create simple, personal and accessible mental health support by combining evidence, cutting-edge tech and user-centered design. We create breakthrough interventions backed by science with one clear goal: to improve people’s mental health. We deliver effective, accessible mental health support that adapts to their unique circumstances. Our international team of behavioral scientists, developers, designers and health innovation leaders work, learn and grow together in a collaborative and inclusive culture. Want to learn more about life at Koa Health? Visit our website at koahealth.com

Impress, Europe’s #1 chain of orthodontic clinics in Europe present in 9 countries and more than 130 cities. Impress clear aligners treatments is the solution recommended by orthodontists to straighten smiles in an easy, discreet and comfortable way. Our orthodontists, with more than 15 years of experience, together with the Impress medical team, design short, personalised treatment plans to achieve results in less than 6 months. More than 50,000 satisfied patients with healthy and aligned smiles.

Methinks vision is to provide universal and timely diagnosis for life-saving treatments worldwide. Our first focus is on stroke, the second cause of death and a major cause of disability in the world. Our product is an artificial intelligence medical imaging software capable of performing stroke triage and unlock stroke treatments potential from non-contrast CTs. Methinks is a VC backed digital health start-up that recently won the prestigious EIC Accelerator of the European Commission and has obtained two gold medals in the RSNA Kaggle competitions. The recent funding of the company will allow us to grow rapidly and we are looking for exceptional and passionate individuals to help us face these challenges and build together a unique company.

Minoryx is a registration stage biotech company focusing on the development of novel therapies for orphan CNS diseases with high unmet medical needs. The company’s lead program, leriglitazone (MIN-102), a novel, brain penetrant and selective PPAR gamma agonist, is being developed in X-linked Adrenoleukodystrophy (X-ALD) and other orphan CNS diseases. The company is backed by a syndicate of experienced investors, which includes Columbus Venture Partners, CDTI Innvierte, Caixa Capital Risc, Fund+, Ysios Capital, Roche Venture Fund, Kurma Partners, Chiesi Ventures, S.R.I.W, Idinvest Partners / Eurazeo, SFPI-FPIM, HealthEquity, Sambrinvest and Herrecha, and has support from a network of other organizations. Minoryx was founded in 2011, is headquartered in Spain with Belgian facilities and has so far raised more than €120 million

Neuronoff, Inc. is developing new medical devices utilizing neuromodulation to restore & improve organ activity in the human body.

Oryzon Genomics, S.A. is a clinical stage biopharmaceutical company and the European leader in the development of epigenetics-based therapeutics, with a strong focus on personalized medicine approaches to CNS disorders and oncology. Oryzon has a broad and growing portfolio, with two compounds in clinical trials: iadademstat, a highly potent and selective LSD1 inhibitor, in Phase IIa clinical trials for the treatment of acute myeloid leukemia and small cell lung cancer, and vafidemstat, a CNS optimized LSD1 inhibitor in multiple Phase II trials for the treatment of CNS and psychiatric diseases. Phase IIb trials for both compounds are under preparation. Our pipeline also includes ORY-3001, a selective LSD1 inhibitor in preclinical development for the treatment of non-oncological diseases, and additional programs for developing inhibitors against other epigenetic targets. Oryzon has a strong technological platform for biomarker identification and performs biomarker and target validation for a variety of malignant and neurological diseases. Oryzon has been listed on the Spanish Stock Exchange since December 2015 (ORY, ISIN Code: ES0167733015). Since then, the company has attracted specialized investors from US, Israel and Europe in several PIPEs led by different US investment banks. The company was founded in 2000 and has offices in Spain and the United States.

HumanITcare is a digital health company delivering a telemedicine platform for monitoring remotely real-life data of chronic patients using Artificial Intelligence. HumanITcare is improving clinical outcomes and reducing clinical costs by providing an accurate remote patient monitoring system.

At ABLE Human Motion we envision a world where everybody has the possibility to move freely. We are a Barcelona-based start-up developing robotic exoskeletons to improve the quality of life of people with disabilities.

Women lack reliable breast cancer (BC) screening methods, as 50% of BCs are detected in a late-stage. At The Blue Box, we've developed a radiation-free, pain-free, low-cost device detecting BC in urine with 88.33%. This outperforms mammography by 15% across all age groups and by 30% for women under 50. By 2025, we aim to introduce this solution in gynecology clinics through a software-driven business model.

Through mediQuo you can chat with doctors and specialists 24 hours a day, 7 days a week, join the health groups and check the medical content of the blog validated by the chat specialists and the team of health advisors.

MedLumics is a medical device company with the goal of taking the latest technological and scientific developments in biophotonics and turning them into innovative and quality products to improve the quality of life. Our work is focused on one of the most successful light-based diagnostic techniques, Optical Coherence Tomography, which is currently seeing rapid expansion and growth. Our disruptive technological advantages allow us to offer unique medical solutions and to develop the clinical applications of this imaging modality. MedLumics, Enlightening Healthcare

L’ Institut IO+D, és un Centre Oftalmològic i Dermatològic de referència a Granollers, amb més de 50 anys. Disposem de la tecnologia i un equip de professionals altament qualificats per acomplir el nostre objectiu que és la prevenció, diagnòstic, tractament i seguiment de les malalties oculars, el sistema visual i els annexes oculars.